Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

Hepatology

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

J Gastroenterol Hepatol.

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH

doi: 10.1111/jgh.15112.

Hepatology

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Liver Transpl

Younossi ZM

doi: 10.1002/lt.25003.

Hepatology

Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality

Am J Gastroenterol.

Kim D, Vazquez-Montesino LM, Escober JA, Fernandes CT, Cholankeril G, Loomba R, Harrison SA, Younossi ZM, Ahmed A

doi: 10.14309/ajg.0000000000000654.

Further Publications

Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

Hepatology

van Kleef L, Ayada I, Alferink L, Pan Q, de Knegt R

doi: 10.1002/hep.32131

Hepatology

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Metabolism.

Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G

doi: 10.1016/j.metabol.

Hepatology

Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution

J Gastroenterol Hepatol.

Chung GE, Heo NJ, Kim D, Kwak MS, Yim JY, Kim JS, Ahmed A

doi: 10.1111/jgh.14778.

Hepatology

Attributable Fractions of NAFLD for Mortality in the United States: Results From NHANES III With 27 Years of Follow-up

Hepatology.

Alvarez CS, Graubard BI, Thistle JE, Petrick JL, McGlynn KA

doi: 10.1002/hep.31040.

Hepatology

A new definition for metabolic associated fatty liver disease: an international expert consensus statement

J Hepatol.

Eslam M, Newsome PN, Anstee QM, Targher G, Gomez MR, Zelber-Sagi S, Wong VW, Dufour JF, Schattenberg J, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Gronbaek H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J

doi: 10.1016/j.jhep.2020.03.039.

Hepatology

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study

Clin Gastroenterol Hepatol.

Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N, Ferro D, Violi F, Sanyal AJ, Del Ben M

doi: 10.1016/j.cgh.2019.12.026.

Related content

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation

Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality

Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: The rotterdam study

Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis

Association between Advanced Fibrosis in Fatty Liver Disease and Overall Mortality based on Body Fat Distribution

Attributable Fractions of NAFLD for Mortality in the United States: Results From NHANES III With 27 Years of Follow-up

A new definition for metabolic associated fatty liver disease: an international expert consensus statement

Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study